Univest
Univest
  • Markets
  • Top 3 Healthcare Stocks to Watch in 2027: Dr Lal PathLabs, Metropolis and Vijaya Diagnostic

    • November 19, 2026
    • Posted by: Harsh Piplani
    • Category: Market
    No Comments
    Top 3 Healthcare Stocks to Watch in 2027: Dr Lal PathLabs, Metropolis and Vijaya Diagnostic

    Dr Lal PathLabs, Metropolis and Vijaya Diagnostic are three healthcare stocks to watch in 2027, compared on September 2026 quarter profit growth, ROE, debt, valuation and 52-week range.

    read more
  • 3 Top Diagnostic Stocks to Watch for Future Multibagger Potential: Dr Lal PathLabs, Vijaya Diagnostic and Metropolis

    • October 16, 2026
    • Posted by: Manan Bisht
    • Category: Best Stocks
    No Comments
    3 Top Diagnostic Stocks to Watch for Future Multibagger Potential: Dr Lal PathLabs, Vijaya Diagnostic and Metropolis

    3 top diagnostic stocks compared on market cap, PE, ROE, growth and institutional holding: Dr Lal PathLabs, Vijaya Diagnostic and Metropolis.

    read more
  • 3 Diagnostic Stocks With a Strong Future Roadmap: Dr. Lal PathLabs, Metropolis Healthcare and Vijaya Diagnostic Centre

    • October 6, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Diagnostic Stocks With a Strong Future Roadmap: Dr. Lal PathLabs, Metropolis Healthcare and Vijaya Diagnostic Centre

    Dr. Lal PathLabs, Metropolis Healthcare and Vijaya Diagnostic Centre compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more
  • Best Diagnostic Stocks in India 2026: Top 4 Pathology Lab Picks With Analyst Targets

    • May 11, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    Best Diagnostic Stocks in India 2026

    Best diagnostic stocks in India 2026 with Dr Lal PathLabs the Rs 23,000 crore quality market leader at 2,100 plus labs, Metropolis Healthcare the premium brand and Krsnaa Diagnostics the fastest growing PPP diagnostic chain as India diagnostic services market targets Rs 2 lakh crore by 2030 and preventive health testing grows at 25 percent.

    read more